23andMe's Pharmacogenetic Test Approved by FDA
23andMe’s Pharmacogenetic Test Approved by FDA
23andMe’s Pharmacogenetic Test Approved by FDA
The FDA has simply authorized 23andMe’s Personal Genomic Service (PGS) Pharmacogenetic Reports. This marks the primary direct-to-consumer check for pharmacogenetics of enzyme variants that can impact the best way sufferers smash down drugs. Consumers acquire their saliva into 23andMe’s checking out package, mail it to the corporate’s labs,…
View On WordPress












